Finance

Beta
Lists
067080:KOSDAQ
Dae Hwa Pharm Co Ltd
₩10,410.00
-2.89%
(-310.00) 1D
Jun 12, 3:30:08 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 067080...
Open
₩11,050
High
₩11,340
Low
₩10,400
Mkt. cap
193.80B
Avg. vol.
95.65K
Volume
0.00
Dividend
1.44%
Quarterly dividend
₩37
Ex-dividend date
Jun 29, 2026
P/E ratio
100.26
52-wk high
₩24,900
52-wk low
₩10,300
EPS
₩104
Shares outstanding
18.62M
No. of employees
365
Open
₩11,050
High
₩11,340
Low
₩10,400
Mkt. cap
193.80B
Avg. vol.
95.65K
Volume
0.00
Dividend
1.44%
Quarterly dividend
₩37
Ex-dividend date
Jun 29, 2026
P/E ratio
100.26
52-wk high
₩24,900
52-wk low
₩10,300
EPS
₩104
Shares outstanding
18.62M
No. of employees
365
News stories
From sources across the web
About Dae Hwa Pharm Co Ltd
CEOEun-Seok Kim | Byung-Tae Noh
Employees365
Founded1984
Headquarters-
SectorPharmaceutical industry
Websitedhpharm.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
35.96B
36.73B
33.70B
37.03B
Cost of goods sold
24.39B
24.78B
22.06B
24.61B
Cost of revenue
24.39B
24.78B
22.06B
24.61B
Research and development expenses
1.54B
1.08B
1.37B
1.22B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.51B
9.27B
9.19B
10.34B
Operating expense
11.29B
10.91B
10.94B
11.97B
Total operating expenses
35.68B
35.68B
33.00B
36.58B
Operating income
285.17M
1.05B
699.48M
453.58M
Other non operating income
408.88M
292.85M
765.41M
303.51M
EBT including unusual items
-362.44M
286.29M
5.00B
-247.88M
EBT excluding unusual items
-394.43M
139.10M
314.23M
-354.75M
Income tax expense
154.81M
465.08M
1.68B
17.77M
Effective tax rate
-42.71%
162.45%
33.52%
-7.17%
Other operating expenses
24.91M
205.24M
89.90M
51.32M
Net income
-682.25M
-428.57M
3.18B
-245.92M
Net profit margin
-1.90%
-1.17%
9.43%
-0.66%
Earnings per share
-
-
-
-
Interest and investment income
59.26M
-14.79M
55.04M
55.34M
Interest expense
-1.17B
-1.09B
-1.27B
-1.23B
Net interest expenses
-1.12B
-1.11B
-1.21B
-1.17B
Depreciation and amortization charges
90.96M
85.92M
89.49M
85.76M
EBITDA
1.85B
2.62B
2.26B
2.01B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer